Therefore, the improvement in glucose homeostasis observed under NCD conditions indicates that targeting adipose Mig-6 could be beneficial not only for diabetes prevention but also as a therapeutic target for non-obese diabetic individuals. Here, ERRFI1 is linked to diabetes mellitus.